I was pleasantly surprised to find out about the fee-free Open Access under the Read & Publish agreement between my institution, Friedrich-Alexander-Universität Erlangen-Nürnberg, and The Company of Biologists. Together with the absence of publication fees and the high reputation of Development in the field, this makes it an ideal journal for scientists like myself who publish some of their research after retirement and therefore no longer have any funds available for this purpose.
Well done to The Company of Biologists for their excellent Read & Publish deals, including with my institution, St George’s, University of London. It’s a great pleasure and benefit for our paper in Biology Open to be immediately available to all, free of charge.
I was really happy to know that our article will be immediately available to researchers (and to any interested reader) around the world under the Read & Publish agreement with the University of Rostock. This way our results will be sooner in the common research domain to inspire discussions, dialogue and further research.
Making Journal of Experimental Biology (JEB) available immediately and without a paywall to the worldwide readership will increase the visibility of the excellent research in experimental and comparative biology carried out by the JEB community, which is particularly important for the early-career researchers.
I would really like to thank Disease Models and Mechanisms journal for the Read & Publish agreement with my university that has allowed publication of my recent article in an efficient and timely way and that is free of charge for the authors. This facility is very useful for many researchers with limited funding, allowing Open Access publishing without financial penalty to authors. The Company of Biologists shows very progressive thinking in this regard.
I am delighted that the Hebrew University of Jerusalem has a Read & Publish agreement with The Company of Biologists for supporting Open Access publication. I published my first two first-author publications as a graduate student in Development, so now publishing again as a PI was an special moment in my career, that showcased the significance of this journal in our field.
I always try to publish Open Access. In this particular paper we reported a method that is widely relevant, which made the impact of the support for Open Access even greater!
I am delighted that the University of Tokyo has a Read & Publish agreement with The Company of Biologists because it ensures that the research published in Development is freely and rapidly available to a wide audience. Our aim is to inform the scientific community and provide timely and accessible access to our valuable findings. We look forward to publishing more open science with The Company of Biologists.
In all honesty, I was as surprised as I was delighted when I heard about the fee-free Open Access option that allowed us to share our work immediately under the Read & Publish initiative. A fantastic model that may be the future. The Company of Biologists is leading the way once again.
Several years ago I made the decision to publish exclusively in non-profit journals, and The Company Of Biologists ranks among the very best. The fact that publishing Open Access in their journals is now fee-free to researchers at my university is just icing on the cake
We are delighted to publish our paper in Disease Models and Mechanisms immediately Open Access under the Read & Publish agreement with University College London. This is an important agreement to allow for free Open Access to our articles, which will allow for immediate dissemination of our work.
I was thrilled to learn that our manuscript got accepted for publication in Journal of Cell Science. The icing on the cake was discovering it would be published fee-free Open Access! Thanks to the Read & Publish agreement with the University of Tübingen, our work became immediately accessible to a wide audience. This not only supports open science but also eases the publishing-associated financial burden, particularly relevant for early-career researchers and those with limited funding. Moreover, this initiative grants us unlimited read access to The Company of Biologists’ hybrid journals.